Jalra-M 50mg/850mg Tablet
Jalra-M 50mg/850mg Tablet
Metformin (850mg) + Vildagliptin (50mg)
Encelin M 50/850 Tablet
Torrent Pharmaceuticals Ltd
Vildagliptin 50mg
Pack Size
strip of 10 tablets
Price
Save ₹249
that's 77% off!
About This Medicine
Product description & overview
Jalra-M 50mg/850mg: A Combined Solution for Type 2 Diabetes Management
Jalra-M 50mg/850mg Tablet is a comprehensive medication designed to effectively manage type 2 diabetes. This unique formulation combines the established antihyperglycemic properties of Metformin (850 mg) with the potency of Vildagliptin (50 mg).
Metformin, widely recognized for its ability to decrease blood glucose levels, helps regulate insulin sensitivity and reduce hepatic glucose production.
Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the body's natural insulin response by promoting incretin hormone activity.
Taken together, Jalra-M provides a well-balanced approach to managing type 2 diabetes, targeting both mechanisms of action for optimal control and improved glycemic control. Consult with your healthcare provider for personalized guidance on dosage and treatment plan adjustments.
Note: This product description is for informational purposes only and should not be considered medical advice. Always consult with a qualified professional before using any medication.
Active composition
Vildagliptin 50 mg
+1 more active ingredient
About Vildagliptin
Vildagliptin is an anti-diabetic medication used to treat type 2 diabetes. It works by inhibiting the DPP-4 enzyme, which increases incretin levels and enhances insulin secretion. Vildagliptin is effective in managing blood sugar levels. Common side effects may include headache and nasopharyngitis, but these usually resolve over time. In summary, Vildagliptin is important for managing diabetes.
How It Works
Vildagliptin inhibits DPP-4, leading to increased levels of incretin hormones, which stimulate insulin secretion and decrease glucagon levels.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Jalra-M 50mg/850mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Jalra-M 50mg/850mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Jalra-M 50mg/850mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jalra-M 50mg/850mg Tablet may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Jalra-M 50mg/850mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jalra-M 50mg/850mg Tablet